Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Kellerer, M., et al., Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial
The Phase 2 results are striking Across several trials, body weight, blood sugar and liver fat improved more in the higher-dose groups, and the pattern was consistent
These include bleeding, infections, heart problems, and a longer hospital stay
Arnolds, S
US$ 21.51
US$ 29.00
US$ 21.26
US$ 25.69
US$ 28.31
US$ 29.77
